Core Viewpoint - The actual controller of the company, Dai Sichong, has postponed the shareholding increase plan from October 8, 2024, to April 7, 2026, involving the entity Songjing Investment and a new foreign entity, Cedarwalk Biotech Hong Kong Limited [1] Summary by Relevant Sections - Shareholding Increase Plan - The shareholding increase plan was initially set to start on October 8, 2024, for a duration of six months but has been delayed to April 7, 2026 [1] - As of February 4, the cumulative increase by Songjing Investment and Guotou Securities International Financial Holdings Co., Ltd. - No. 2 Investment Plan reached 6.3757 million shares, accounting for 1.67531% of the total share capital [1] - Recent Shareholding Changes - From November 2025 to February 4, a total of 5.0763 million shares were increased, representing 1.33388% of the total share capital [1] - The shareholding of Songjing Investment and its concerted parties has risen to 13.99607% following the recent increases [1] - Potential Implementation Issues - The shareholding increase plan may not be fully implemented due to market and other factors [1]
保龄宝:实际控制人企业增持计划新增主体,权益变动达1%